ask="19.50"
ask_size="3600"
average_daily_volume="147443"
bid="12.00"
bid_size="100"
book_value="6.01"
change="-0.21"
change_from_200_day_moving_average="1.16"
change_from_50_day_moving_average="0.42"
change_from_52_week_high="-2.25"
change_From_52_week_low="5.18"
change_in_percent="-1.20%"
close="17.25"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.77"
ebitda="-62.58M"
eps_estimate_current_year="-3.16"
eps_estimate_next_quarter="-0.77"
eps_estimate_next_year="-1.76"
ex_dividend_date="N/A"
float_shares="11847000"
high="17.38"
high_52_weeks="19.50"
last_trade_date="3/14/2017"
last_trade_price="17.25"
last_trade_size="2417"
last_trade_time="4:00pm"
low="16.78"
low_52_weeks="12.07"
market_capitalization="383.28M"
moving_average_200_day="16.09"
moving_average_50_day="16.83"
name="Adamas Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="32.38"
open="17.38"
pe_ratio="N/A"
peg_ratio="-0.07"
percent_change_from_200_day_moving_average="+7.23%"
percent_change_from_50_day_moving_average="+2.51%"
percent_change_from_52_week_high="-11.54%"
percent_change_from_52_week_low="+42.92%"
previous_close="17.46"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.91"
price_per_sales="678.22"
revenue="572000.00"
shares_outstanding="22219000"
short_ratio="31.81"
stock_exchange="NGM"
symbol="ADMS"
volume="72352"
weeks_range_52="12.07 - 19.50"
